Evaluation of colistin nephrotoxicity administered at different doses in the rat model

References

• Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333–1341
   PubMed Web of Science ®Google Scholar
• Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta. 2005;351:31–47
   PubMed Web of Science ®Google Scholar
• Kocaoglu S, Karan A, Berkan T, et al. Acute acetaminophen nephrotoxicity and urinary gamma-glutamyl transferase activity in rats. Drug Metabol Drug Interact. 1997;14:47–54
   PubMedGoogle Scholar
• Naghibi B, Ghafghazi T, Hajhashemi V, et al. Vancomycin induced nephrotoxicity in rats: is enzyme elevation a consistent finding in tubular injury? J Nephrol. 2007;20:482–488
   PubMed Web of Science ®Google Scholar
• Gumbleton M, Nicholls PJ. Dose-response and time-response biochemical and histological study of potassium dichromate-induced nephrotoxicity in the rat. Food Chem Toxicol. 1988;26:37–44
   PubMed Web of Science ®Google Scholar
• da Silva Melo DA, Saciura VC, Poloni JA, et al. Evaluation of renal enzymuria and cellular excretion as a marker of acute nephrotoxicity due to an overdose of paracetamol in Wistar rats. Clin Chim Acta. 2006;373:88–91
   PubMed Web of Science ®Google Scholar
• Stonard MD, Gore CW, Oliver GJ, et al. Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney. Fundam Appl Toxicol. 1987;9:339–351
   PubMedGoogle Scholar
• Herget-Rosenthal S, Marggraf G, Hüsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66:1115–1122
   PubMed Web of Science ®Google Scholar
• Herget-Rosenthal S, van Wijk JA, Bröcker-Preuss M, et al. Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem. 2007;40:946–951
   PubMed Web of Science ®Google Scholar
• Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534–2543
   PubMed Web of Science ®Google Scholar
• Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54:1012–1024
   PubMed Web of Science ®Google Scholar
• Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, et al. Treatment of multidrug-resistant Acinetobacter baumanii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis. 2003;36:1111–1118
   PubMed Web of Science ®Google Scholar
• Hakim A, Kallel H, Sahnoun Z, et al. Lack of nephrotoxicity following 15-day therapy with high doses of colistin in rats. Med Sci Monit. 2008;14:74–77
   Web of Science ®Google Scholar
• Ozyilmaz E, Ebinc FA, Derici U, et al. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? Intensive Care Med. 2010;37:141–146
   Google Scholar
• Li J, Milne RW, Nation RL, et al. Use of high performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob Agents Chemother. 2003;47:1766–1770
   PubMed Web of Science ®Google Scholar
• Yousef JM, Chen G, Hill PA, et al. Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob Agents Chemother. 2011;55:4044–4049
   PubMed Web of Science ®Google Scholar
• Hoeprich PD. The polymyxins. Med Clin North Am. 1970;54:1257–1265
   PubMed Web of Science ®Google Scholar
• Wallace SJ, Li J, Nation RL, et al. Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens. Antimicrob Agents Chemother. 2008;52:1159–1161
   PubMed Web of Science ®Google Scholar
• Conti M, Moutereau S, Zater M, et al. Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med. 2006;44:288–291
   PubMed Web of Science ®Google Scholar
• European Medicines Agency (EMEA). Final report on the pilot joint EMEA/FDA VXDs experience on quantification of nephrotoxicity biomarkers, Available at: www.emea.europa.eu/pdfs/human/biomarkers/2008/25088508en.pdf September 2010, Accessed May 6, 2010
   Google Scholar
• Ferguson MA, Vaidya VS, Bonventre JV. Biomarkers of nephrotoxic acute kidney injury. Toxicology. 2008;245:182–193
   PubMed Web of Science ®Google Scholar
• Tonomura Y, Tsuchiya N, Torii M, et al. Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats. Toxicology. 2010;273:53–59
   Google Scholar
• Sasaki D, Yamada A, Umeno H, et al. Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury. Biomarkers. 2011;16:553–566
   PubMed Web of Science ®Google Scholar
• Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008;23:2151–2157
   PubMed Web of Science ®Google Scholar
• Devarajan P. Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin Med Diagn. 2008;2:387–398
   PubMedGoogle Scholar
• Kuwabara T, Mori K, Mukoyama M, et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009;75:285–294
   PubMed Web of Science ®Google Scholar
• Koyner JL, Vaidya VS, Bennett MR, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010;5:2154–2165
   PubMed Web of Science ®Google Scholar
• D’Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int. 2003;63:809–825
   PubMed Web of Science ®Google Scholar
• Whiting PH, Brown PA. The relationship between enzymuria and kidney enzyme activities in experimental gentamicin nephrotoxicity. Ren Fail. 1996;18:899–909
   PubMed Web of Science ®Google Scholar